Subscribe to RSS
DOI: 10.1055/a-2805-9830
Long-Term Prognostic Impact of the Dural Tail in the Local Control of Intracranial Meningiomas
Authors
Abstract
Objective
The role of dural tail resection in meningioma surgery remains controversial. While many surgeons consider completeness of resection dependent on the removal of involved dura, histological studies have provided inconsistent evidence of neoplastic infiltration. Furthermore, the prognostic benefit of including the dural tail in resection or radiation fields is unclear, and many prior studies lack long-term follow-up. This study evaluated the long-term impact of dural tail resection on local control of intracranial meningiomas.
Methods
We retrospectively analyzed patients with surgically treated meningiomas from 2000 to 2015. Those receiving postoperative radiation were excluded. Radiological features of the dural tail were reviewed and correlated with tumor grade and extent of resection.
Results
A total of 101 patients were included; 78 (77.2%) had WHO grade I tumors. Complete resection, including the dural tail, was achieved in 63 patients (62.3%). Median follow-up was 127.1 months (IQR: 89.6–170.1). The overall recurrence rate was 9%, with a median time to recurrence of 52 months. Radiologic dural tail subtypes had no significant prognostic impact (p = 0.57) and showed no correlation with higher tumor grade. However, omission of dural tail resection negatively affected progression-free survival (PFS): 10-year PFS was 79% without dural tail removal versus 98% with dural tail resection (hazard ratio: 4.5; 95% CI, 1.13–18.2; p = 0.03). This association remained significant on multivariate Cox regression analysis (p = 0.04).
Conclusion
In this large cohort with extended follow-up, dural tail resection significantly improved long-term PFS, supporting its inclusion in the surgical management of intracranial meningiomas.
Keywords
clinical outcomes - dural tail - dural thickening - long-term follow-up - meningioma - prognosisNote
This article was presented as a poster at the NASBS 2024 conference, under the title “Long-term Prognostic Impact of the Dural Tail in the Local Control of Intracranial Meningiomas.”
Publication History
Received: 08 October 2025
Accepted: 04 February 2026
Accepted Manuscript online:
06 February 2026
Article published online:
18 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Nasrallah MP, Aldape KD. Molecular classification and grading of meningioma. J Neurooncol 2023; 161 (02) 373-381
- 2 Goldbrunner R, Minniti G, Preusser M. et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 2016; 17 (09) e383-e391
- 3 Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20 (01) 22-39
- 4 Brokinkel B, Spille DC, Brokinkel C. et al. The Simpson grading: defining the optimal threshold for gross total resection in meningioma surgery. Neurosurg Rev 2021; 44 (03) 1713-1720
- 5 Sughrue ME, Kane AJ, Shangari G. et al. The relevance of Simpson grade I and II resection in modern neurosurgical treatment of WHO grade I meningiomas. J Neurosurg 2010; 113 (05) 1029-1035
- 6 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131 (06) 803-820
- 7 Sotoudeh H, Yazdi HR. A review on dural tail sign. World J Radiol 2010; 2 (05) 188-192
- 8 Liu WC, Choi G, Lee SH. et al. Radiological findings of spinal schwannomas and meningiomas: focus on discrimination of two disease entities. Eur Radiol 2009; 19 (11) 2707-2715
- 9 Guermazi A, Lafitte F, Miaux Y, Adem C, Bonneville JF, Chiras J. The dural tail sign–beyond meningioma. Clin Radiol 2005; 60 (02) 171-188
- 10 Slot KM, Verbaan D, Uitdehaag BM. et al. Can excision of meningiomas be limited to resection of tumor and radiologically abnormal dura mater?. Neuronavigation-guided biopsies of dural tail and seemingly normal dura mater, with a review of the literature. Meningioma Surg 2014; 29
- 11 Rokni-Yazdi H, Azmoudeh Ardalan F, Asadzandi Z. et al. Pathologic significance of the “dural tail sign.”. Eur J Radiol 2009; 70 (01) 10-16
- 12 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61 (04) 344-349
- 13 Goldsher D, Litt AW, Pinto RS, Bannon KR, Kricheff II. Dural “tail” associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology 1990; 176 (02) 447-450
- 14 Qi ST, Liu Y, Pan J, Chotai S, Fang LX. A radiopathological classification of dural tail sign of meningiomas. J Neurosurg 2012; 117 (04) 645-653
- 15 Kinjo T, al-Mefty O, Kanaan I. Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 1993; 33 (03) 394-399 , discussion 399
- 16 de Carvalho GTC, da Silva-Martins WC, de Magalhães KCSF. et al. Recurrence/regrowth in grade I meningioma: how to predict?. Front Oncol 2020; 10: 1144
- 17 Borovich B, Doron Y. Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 1986; 64 (01) 58-63
- 18 Black PM, Morokoff AP, Zauberman J. Surgery for extra-axial tumors of the cerebral convexity and midline. Neurosurgery 2008; 62 (6, suppl 3): 1115-1121 , discussion 1121–1123
- 19 Jääskeläinen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986; 26 (05) 461-469
- 20 Levine ZT, Buchanan RI, Sekhar LN, Rosen CL, Wright DC. Proposed grading system to predict the extent of resection and outcomes for cranial base meningiomas. Neurosurgery 1999; 45 (02) 221-230
- 21 Gousias K, Schramm J, Simon M. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg 2016; 125 (03) 551-560
- 22 Hasseleid BF, Meling TR, Rønning P, Scheie D, Helseth E. Surgery for convexity meningioma: Simpson grade I resection as the goal: clinical article. J Neurosurg 2012; 117 (06) 999-1006
- 23 Nakau H, Miyazawa T, Tamai S. et al. Pathologic significance of meningeal enhancement (“flare sign”) of meningiomas on MRI. Surg Neurol 1997; 48 (06) 584-590 , discussion 590–591
- 24 Murase M, Tamura R, Kuranari Y. et al. Novel histopathological classification of meningiomas based on dural invasion. J Clin Pathol 2021; 74 (04) 238-243
- 25 Nagashima G, Fujimoto T, Suzuki R, Asai J, Itokawa H, Noda M. Dural invasion of meningioma: a histological and immunohistochemical study. Brain Tumor Pathol 2006; 23 (01) 13-17
- 26 Tokumaru A, O'uchi T, Eguchi T. et al. Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology 1990; 175 (02) 431-433
- 27 Nägele T, Petersen D, Klose U, Grodd W, Opitz H, Voigt K. The “dural tail” adjacent to meningiomas studied by dynamic contrast-enhanced MRI: a comparison with histopathology. Neuroradiology 1994; 36 (04) 303-307
- 28 Aoki S, Sasaki Y, Machida T, Tanioka H. Contrast-enhanced MR images in patients with meningioma: importance of enhancement of the dura adjacent to the tumor. AJNR Am J Neuroradiol 1990; 11 (05) 935-938
- 29 Wilms G, Lammens M, Marchal G. et al. Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. AJNR Am J Neuroradiol 1991; 12 (04) 761-764
- 30 Piper K, Yu S, Taghvaei M. et al. Radiation of meningioma dural tail may not improve tumor control rates. Front Surg 2022; 9: 908745
- 31 Mathiesen T, Lindquist C, Kihlström L, Karlsson B. Recurrence of cranial base meningiomas. Neurosurgery 1996; 39 (01) 2-7 , discussion 8–9
- 32 Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985; 62 (01) 18-24
- 33 Lee YS, Lee YS. Molecular characteristics of meningiomas. J Pathol Transl Med 2020; 54 (01) 45-63
- 34 Teske N, Biczok A, Quach S. et al. Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1. Eur J Nucl Med Mol Imaging 2023; 51 (01) 206-217
